Nutrition therapy of the severely obese, critically ill patient: Summation of conclusions and recommendations

Journal of Parenteral and Enteral Nutrition

Volumn 35, Issue 5 SUPPL., 2011, Pages

  McClave, Stephen A ^a   Kushner, Robert ^b   Van Way III, Charles W ^c   Cave, Matt ^a   DeLegge, Mark ^d   Dibaise, John ^e   Dickerson, Roland ^f   Drover, John ^g   Frazier, Thomas H ⁿ   Fujioka, Ken ^h   Gallagher, Dympna ⁱ   Hurt, Ryan T ^e   Kaplan, Lee ^j   Kiraly, Lazlo ^k   Martindale, Robert ^k   Craig McClain, ^l   Ochoa, Juan ^m  

^a University of Louisville School of Medicine   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g QUEEN S UNIVERSITY   (Canada)

^h SCRIPPS CLINIC   (United States)

ⁱ Och Spine at New York Presbyterian Hospitals   (United States)

^j HARVARD UNIVERSITY   (United States)

^k OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^l UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

^m UNIVERSITY OF PITTSBURGH   (United States)

ⁿ NONE

more..

Author keywords

Critical illness; Enteral nutrition; Hypocaloric feeding; Obesity; Pharmaconutrition

Indexed keywords

ALPHA TOCOPHEROL; ARGININE; FISH OIL; LEUCINE; MAGNESIUM; THIOCTIC ACID; ZINC;

ARTICLE; BARIATRIC SURGERY; BODY MASS; CRITICALLY ILL PATIENT; DIET THERAPY; ENTERIC FEEDING; HUMAN; IMMUNOMODULATION; INTENSIVE CARE UNIT; LEAN BODY WEIGHT; NUTRITIONAL ASSESSMENT; OBESITY; PRIORITY JOURNAL; BODY COMPOSITION; CALORIC RESTRICTION; CRITICAL ILLNESS; ELEMENTAL DIET; INTENSIVE CARE; METHODOLOGY; PRACTICE GUIDELINE; RISK FACTOR; TREATMENT OUTCOME;

BARIATRIC SURGERY; BODY COMPOSITION; BODY MASS INDEX; CALORIC RESTRICTION; CRITICAL CARE; CRITICAL ILLNESS; ENTERAL NUTRITION; FOOD, FORMULATED; HUMANS; INTENSIVE CARE UNITS; NUTRITION ASSESSMENT; OBESITY; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 84855410642     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607111415111     Document Type: Article

References (47)

1. Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes (Lond). 2009;33(3):289-295.
2. Wellens RI, Roche AF, Khamis HJ, et al. Relationships between body mass index and body composition. Obes Res. 1996;4:35-44.
3. Wang Y, Beydoun MA. The obesity epidemic in the United States- gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007;29:6.
4. Hogue CW Jr, Stearns JD, Colantuoni E, et al. The impact of obesity on outcomes after critical illness: a meta-analysis. Intensive Care Med. 2009;35(7):1152-1170.
5. Joffe A, Wood K. Obesity in critical care. Curr Opin Anaesthesiol. 2007;20(2):113-118.
6. Honiden S, McArdle JR. Obesity in the intensive care unit. Clin Chest Med. 2009;30(3):581-599.
7. El-Solh A, Sikka P, Bozkanat E, Jaafar W, Davies J. Morbid obesity in the medical ICU. Chest. 2001;120(6):1989-1997.
8. Port AM, Apovian C. Metabolic support of the obese intensive care unit patient: a current perspective. Curr Opin Clin Nutr Metab Care. 2010;13:184-191.
9. Pieracci FM, Barie PS, Pomp A. Critical care of the bariatric patient. Crit Care Med. 2006;34(6):1796-1804.
10. Elamin EM. Nutritional care of the obese intensive care unit patient. Curr Opin Crit Care. 2005;11(4):300-303.
11. Cave MC, Hurt RT, Frazier TH, et al. Obesity, inflammation, and the potential application of pharmaconutrition. Nutr Clin Pract. 2008;23(1):16-34.
12. McClave SA, Martindale RG, Vanek VW, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2009;33:277-316.
13. Sakr Y, Madl C, Filipescu D, et al. Obesity is associated with increased morbidity but not mortality in critically ill patients. Intensive Care Med. 2008;34:1999-2009.
14. Akinnusi ME, Pineda LA, El Solh AA. Effect of obesity on intensive care morbidity and mortality: a meta-analysis. Crit Care Med. 2008;36(1):151-158.
15. Brown CV, Velmahos GC. The consequences of obesity on trauma, emergency surgery, and surgical critical care. World J Emerg Surg. 2006;1:27.
16. Goulenok C, Monchi M, Chiche JD, Mira JP, Dhainaut JF, Cariou A. Influence of overweight on ICU mortality: a prospective study. Chest. 2004;125(4):1441-1445.
17. Bercault N, Boulain T, Kuteifan K, Wolf M, Runge I, Fleury JC. Obesity-related excess mortality rate in an adult intensive care unit: a risk-adjusted matched cohort study. Crit Care Med. 2004;32(4):998-1003.
18. Frankenfield D. Energy dynamics. In: Matarese L, Gottschlich M, eds. Contemporary Nutrition Support Practice. Philadelphia: W. B. Saunders; 1998:84.
19. Ireton-Jones C, Jones JD. Improved equations for predicting energy expenditure in patients: the Ireton-Jones equations. Nutr Clin Pract. 2002;17:29-31.
20. Mifflin MD, St Jeor ST, Hill LA, et al. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr. 1990;51:241-247.
21. Choban PS, Dickerson RN. Morbid obesity and nutrition support: is bigger different? Nutr Clin Pract. 2005;20(4):480-487.
22. Dickerson RN, Tidwell AC, Minard G, Groce MA, Brown RO. Predicting total urinary nitrogen excretion from urine urea nitrogen excretion in multiple trauma patients receiving specialized nutritional support. Nutrition. 2005;21:332-338.
23. Metheny NA, Stewart BJ, McClave SA. Relationship between feeding tube site and respiratory outcomes. JPEN J Parenter Enteral Nutr. 2011;35:346-355.
24. Wheaton G, Marden P, Colleypriest B, et al. Understanding why patients die after gastrostomy tube insertion: a retrospective analysis of mortality. JPEN J Parenter Enteral Nutr. 2009;33:375-379.
25. Schweiger C, Weiss R, Berry E, et al. Nutritional deficiencies in bariatric surgery candidates. Obes Surg. 2010;20(2):193-197.
26. Al-Fahad T, Ismael A, Soliman MO, et al. Very early onset of Wernicke's encephalopathy after gastric bypass. Obes Surg. 2006;16:671-672.
27. Kazemi A, Frazier T, Cave M. Micronutrient-related neurologic complications following bariatric surgery. Curr Gastroenterol Rep. 2010;12(4):288-295.
28. Juhasz-Pocsine K, Rudnicki SA, Archer RL, et al. Neurologic complications of gastric bypass surgery for morbid obesity. Neurology. 2007;68:1843-1850.
29. Reeds DN. Nutrition support in the obese, diabetic patient: the role of hypocaloric feeding. Curr Opin Gastroenterol. 2009;25: 151-154.
30. Dickerson RN. Hypocaloric feeding of obese patients in the intensive care unit. Curr Opin Clin Nutr Metab Care. 2005;8(2): 189-196.
31. McClave SA. Do peptide-based enteral formulas provide any benefit over intact protein diets? Nutrition. 1995;11(4):395-397.
32. Hurt RT, Frazier TH, Matheson PJ, et al. Obesity and inflammation: should the principles of immunonutrition be applied to this disease process? Curr Gastroenterol Rep. 2007;9(4):305-306.
33. Boger RH. The pharmacodynamics of L-arginine. J Nutr. 2007;137(6)(suppl 2):1650S-1655S.
34. McKnight JR, Satterfield MC, Jobgen WS, et al. Beneficial effects of L-arginine on reducing obesity: potential mechanisms and important implications for human health. Amino Acids. 2010;39(2): 349-357.
35. Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys. 2007;458(1):40-47.
36. Powell SR. The antioxidant properties of zinc. J Nutr. 2000;130(5) (suppl):1447S-1454S.
37. Singh RB, Niaz MA, Rastogi SS, Bajaj S, Gaoli Z, Shoumin Z. Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr. 1998;17(6):564-570.
38. Layman DK, Walker DA. Potential importance of leucine in treatment of obesity and the metabolic syndrome. J Nutr. 2006;136(1) (suppl):319S-323S.
39. Li H, Ruan XZ, Powis SH, et al. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gammadependent mechanism. Kidney Int. 2005;67(3):867-874.
40. Lo CJ, Chiu KC, Fu M, Lo R, Helton S. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. J Surg Res. 1999;82(2):216-221.
41. Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010; 362:1675-1685.
42. Kamenova P. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid. Hormones (Athens). 2006;5(4):251-258.
43. DiBaise JK, Zhang H, Crowell MD, Krajmalnik-Brown R, Decker GA, Rittmann BE. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc. 2008;83(4):460-469.
44. Aggarwal BB. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr. 2010;30:173-199.
45. Zheng S, Chen A. Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am J Physiol. 2006;290:G883-G893.
46. Veldorst MAB, Nieuwenhuizewn AC, Waelen AH, et al. Dosedependent satiating effect of whey relative to casein or soy. Physiol Behav. 2009;96:675-682.
47. McClave SA, Saad MA, Jotautas AE, et al. Volume-based feeding in the critically ill patient. JPEN J Parenter Enteral Nutr. 2011;35(1):134-135.